Bio:

Bryan Gore joined the Allen Institute for Brain Science in 2019. As a member of the Human Cell Types group, Bryan leads several therapeutic indications in the Gene Therapy Program, focusing on in vivo modeling of genetic epilepsies, including Dravet Syndrome. Prior to the Allen Institute, he completed a postdoctoral fellowship at the University of Washington where he studied inhibitory control of the dopamine neuron system. Bryan performed graduate studies at Stanford and Genentech on the molecular mechanisms of neural development. He received his PhD in neuroscience from Stanford University, and BA in English and BS in biochemistry from the University of Washington.